Phospholipase A2-mediated inflammation induces regression of malignant gliomas

Cancer Letters

Volumn 102, Issue 1-2, 1996, Pages 1-6

  Goddard, David H ^a,b   Bomalaski, John S ^c   Lipper, Stanley ^b,d   Shorr, Robert G L ^e   Clark, Mike A ^e  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

^e Enzon Incorporated   (United States)

Author keywords

Eicosanoids; Gliomas; Inflammation; Natural killer cells; Phospholipases

Indexed keywords

ENZYME ACTIVATOR; LEUKOTRIENE B4; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ACTIVATING PROTEIN; PHOSPHOLIPASE A2-ACTIVATING PROTEIN; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLIOBLASTOMA; ICOSANOID METABOLISM; IMMUNOSTIMULATION; INFLAMMATION; INTRATUMORAL DRUG ADMINISTRATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME; AMINO ACID SEQUENCE; ANIMAL; CANCER TRANSPLANTATION; CELL DIVISION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GLIOMA; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NECROSIS; PATHOLOGY; PHYSIOLOGY; STAINING; WISTAR RAT;

ANIMALIA; MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOMA; INFLAMMATION; LEUKOTRIENE B4; MOLECULAR SEQUENCE DATA; NECROSIS; NEOPLASM TRANSPLANTATION; PHOSPHOLIPASES A; PROTEINS; RATS; RATS, WISTAR; STAINING AND LABELING;

EID: 0029670232     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04142-0     Document Type: Article

References (29)

1. Thomas, L. (1959) In: Cellular and Humoral Aspects of the Hypersensitivity State, pp. 529-532. Editor: H.S. Lawrence, Cassel Publishing, London.
2. 2. Cell Immunol., 123, 384-395.
3. Baxevanis, C.N., Reclos, G.J., Gritzapis, A.D., Dedousis, G.V.Z., Missitzis, I. and Papamichail, M. (1993) Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer, 72, 491-501.
4. 2 activity. J. Biol. Chem. 261, 10713-10718.
5. 2-activating protein in endothelial cells. Biochem. J., 250, 125-132.
6. Aderem, A.A., Scott, W.A. and Cohn, Z.A. (1986) Evidence for sequential signals in the induction of the arachidonic acid cascade in macrophages. J. Exp. Med., 163, 139-154.
7. 1-adrenergic stimulation in FRTL5 thyroid cells. Proc. Natl. Acad. Sci. USA, 83, 7201-7205.
8. 2. Proc. Natl. Acad. Sci. USA, 84, 6374-6378.
9. Dempsey, C.E. (1990) The actions of melittin on membranes. Biochim. Biophys. Acta, 1031, 143-161.
10. 2 activating protein. Proc. Natl. Acad. Sci. USA, 88, 5418-5422.
11. 2 activating protein (PLAP) in rheumatoid arthritis: induction of eicosanoid synthesis and the induction of the inflammatory response in joints injected with PLAP in vivo. J. Lab. Clin. Med., 116, 814-825.
12. 2 activating protein (PLAP) and melittin. Biochim. Biophys. Acta, 1166, 124-130.
13. 2 activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, Superoxide and eicosanoids. J. Immunol., 142, 3957-3962.
14. 2-activating protein induces the synthesis of IL-1 and TNF in human monocytes. J. Immunol., 154, 4027-4031.
15. Kornblith, P.L. and Walker, M. (1988) Chemotherapy for malignant gliomas. J. Neurosurg., 68, 1-17.
16. Braganca, B.M. and Hospattankar, A.V. (1978) Potentiating action of cobra venom cytotoxin on the antitumour effects of an alkylating agent (melphalan). Eur. J. Cancer, 14, 707-712.
17. Walker, M.D., Green, S.B., Byar, D.P. et. al. (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med., 303, 1323-1329.
18. DeBrito, F.B., Moore, A.R., Corry, D.G. and Willoughby, D.A. (1987) A time course study of the changes that occur to the subcutaneous model of synovium following polyarthritogen. Br. J. Exp. Pathol., 68, 559-567.
19. Goddard, D., Bruno, G., Baker, D. and Carsons, S. (1994) Cytokine and extracellular matrix expression in the maturing rat air pouch. Arthritis Rheum., 37, 191.
20. 2 activation caused by tumor necrosis factor. J. Immunother., 12, 41-49.
21. Hugosson, M., Andreu, D., Boman, H.G. and Glaser, E. (1994) Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import. Eur. J. Biochem., 223, 1027-1033.
22. Rotman, E.I., Brostrom, M.A. and Brostrom, C.O. (1992) Inhibition of protein synthesis in intact mammalian cells by arachidonic acid. J. Biochem. (Tokyo), 282, 487-495.
23. Glasgow, W.C., Afshari, C.A., Barrett, J.C. and Eling, T.E. (1992) Modulation of the epidermal growth factors mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts: differential effects in tumor suppressor gene (+) and (-) phenotypes. J. Biol. Chem., 267, 10771-10779.
24. Aste-Amezaga, M., D'Andrea, A., Kubin, M. and Trinchieri, G. (1994) Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK-cells. Cell. Immunol., 156, 480-492.
25. Hill, L.L., Perussia, B., McCue, P.A. and Korngold, R. (1994) Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res., 54, 736-770.
26. Trinchieri, G. (1994) Recognition of major histocompatibility complex class I antigens by natural killer cells (Review). J. Exp. Med., 180, 417-421.
27. Pastan, I., Chaudhary, V. and FitzGerald, D.J. (1992) Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem., 61, 331-354.
28. 2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK-cells. Cell Immunol., 148, 247-258.
29. 2. Cell Immunol., 139, 248-258.